The majority of these studies on ITAC, SNSCC and ONB showed CD8+ TILs to be associated with better prognosis, while PD-L1 expression on tumor cells or macrophages generally did not carry prognostic value [22,24,26,28]. This evidence concerns the gene CD8A and neoplasm.